FdaApplication

ANDA 204740

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAMNEAL PHARMACEUTICALS OF NEW YORK LLC
application_typeANDA
approval_date2018-04-17

Products (3)

ProductActive ingredientStrengthDosage form
IRBESARTANIRBESARTAN75MGTABLET;ORAL
IRBESARTANIRBESARTAN300MGTABLET;ORAL
IRBESARTANIRBESARTAN150MGTABLET;ORAL

3 products